Nonintegrating foamy virus vectors

Journal of Virology

Volumn 84, Issue 18, 2010, Pages 9341-9349

  Deyle, David R ^a   Li, Yi ^a   Olson, Erik M ^a   Russell, David W ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIRCULAR DNA; CRE RECOMBINASE; VIRUS VECTOR; INTEGRASE; VIRUS PROTEIN;

ARTICLE; CELL POPULATION; DNA INTEGRATION; DNA ISOLATION; EPISOME; GENE EXPRESSION; GENE TARGETING; GENOME; HOST RANGE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LONG TERMINAL REPEAT; NONHUMAN; PLASMID; POINT MUTATION; PRIORITY JOURNAL; SPUMA VIRUS; TRANSGENE; TRANSIENT EXPRESSION; VIRUS TITRATION; DEFICIENCY; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; MISSENSE MUTATION; VIRUS DNA CELL DNA INTERACTION;

GENETIC VECTORS; HUMANS; INTEGRASES; MUTATION, MISSENSE; POINT MUTATION; SPUMAVIRUS; TRANSDUCTION, GENETIC; VIRAL PROTEINS; VIRUS INTEGRATION;

EID: 77956025823     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00394-10     Document Type: Article

References (63)

1. Apolonia, L., S. N. Waddington, C. Fernandes, N. J. Ward, G. Bouma, M. P. Blundell, A. J. Thrasher, M. K. Collins, and N. J. Philpott. 2007. Stable gene transfer to muscle using non-integrating lentiviral vectors. Mol. Ther. 15: 1947-1954.
2. Bauer, T. R., Jr., J. M. Allen, M. Hai, L. M. Tuschong, I. F. Khan, E. M. Olson, R. L. Adler, T. H. Burkholder, Y. C. Gu, D. W. Russell, and D. D. Hickstein. 2008. Successful treatment of canine leukocyte adhesion deficiency by foamy virus vectors. Nat. Med. 14:93-97.
3. Baum, C., S. Hegewisch-Becker, H. Eckert, C. Stocking, and W. Ostertag. 1995. Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells. J. Virol. 69:7541-7547.
4. Bayer, M., B. Kantor, A. Cockrell, H. Ma, B. Zeithaml, X. Li, T. McCown, and T. Kafri. 2008. A large U3 deletion causes increased in vivo expression from a nonintegrating lentiviral vector. Mol. Ther. 16:1968-1976.
5. Butler, S. L., M. S. Hansen, and F. D. Bushman. 2001. A quantitative assay for HIV DNA integration in vivo. Nat. Med. 7:631-634.
6. Chamberlain, J. R., D. R. Deyle, U. Schwarze, P. Wang, R. K. Hirata, Y. Li, P. H. Byers, and D. W. Russell. 2008. Gene targeting of mutant COL1A2 alleles in mesenchymal stem cells from individuals with osteogenesis imperfecta. Mol. Ther. 16:187-193.
7. Coffin, J. M., S. H. Hughes, and H. Varmus. 1997. Retroviruses. Cold Spring Harbor Laboratory Press, Plainview, NY.
8. Cornu, T. I., and T. Cathomen. 2007. Targeted genome modifications using integrase-deficient lentiviral vectors. Mol. Ther. 15:2107-2113.
9. Delelis, O., C. Petit, H. Leh, G. Mbemba, J. F. Mouscadet, and P. Sonigo. 2005. A novel function for spumaretrovirus integrase: an early requirement for integrase-mediated cleavage of 2 LTR circles. Retrovirology 2:31.
10. Delelis, O., A. Saib, and P. Sonigo. 2003. Biphasic DNA synthesis in spumaviruses. J. Virol. 77:8141-8146.
11. Dina, D., and E. W. Benz, Jr. 1980. Structure of murine sarcoma virus DNA replicative intermediates synthesized in vitro. J. Virol. 33:377-389.
12. Enssle, J., A. Moebes, M. Heinkelein, M. Panhuysen, B. Mauer, M. Schweizer, D. Neumann-Haefelin, and A. Rethwilm. 1999. An active foamy virus integrase is required for virus replication. J. Gen. Virol. 80(Pt. 6):1445-1452.
13. Falcone, V., M. Schweizer, and D. Neumann-Haefelin. 2003. Replication of primate foamy viruses in natural and experimental hosts. Curr. Top. Microbiol. Immunol. 277:161-180.
14. Gharwan, H., R. K. Hirata, P. Wang, R. E. Richard, L. Wang, E. Olson, J. Allen, C. B. Ware, and D. W. Russell. 2007. Transduction of human embryonic stem cells by foamy virus vectors. Mol. Ther. 15:1827-1833.
15. Gilboa, E., S. Goff, A. Shields, F. Yoshimura, S. Mitra, and D. Baltimore. 1979. In vitro synthesis of a 9 kbp terminally redundant DNA carrying the infectivity of Moloney murine leukemia virus. Cell 16:863-874.
16. Graham, F. L., J. Smiley, W. C. Russell, and R. Nairn. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:59-72.
17. Haas, D. L., S. S. Case, G. M. Crooks, and D. B. Kohn. 2000. Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors. Mol. Ther. 2:71-80.
18. Hawley, R. G., F. H. Lieu, A. Z. Fong, and T. S. Hawley. 1994. Versatile retroviral vectors for potential use in gene therapy. Gene Ther. 1:136-138.
19. Heinkelein, M., T. Pietschmann, G. Jarmy, M. Dressler, H. Imrich, J. Thurow, D. Lindemann, M. Bock, A. Moebes, J. Roy, O. Herchenroder, and A. Rethwilm. 2000. Efficient intracellular retrotransposition of an exogenous primate retrovirus genome. EMBO J. 19:3436-3445.
20. Heinkelein, M., M. Rammling, T. Juretzek, D. Lindemann, and A. Rethwilm. 2003. Retrotransposition and cell-to-cell transfer of foamy viruses. J. Virol. 77:11855-11858. (Pubitemid 37271684)
21. Hendrie, P. C., Y. Huo, R. B. Stolitenko, and D. W. Russell. 2008. A rapid and quantitative assay for measuring neighboring gene activation by vector proviruses. Mol. Ther. 16:534-540.
22. Heneine, W., M. Schweizer, P. Sandstrom, and T. Folks. 2003. Human infection with foamy viruses. Curr. Top. Microbiol. Immunol. 277:181-196.
23. Hirt, B. 1967. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26:365-369.
24. Josephson, N. C., G. Trobridge, and D. W. Russell. 2004. Transduction of long-term and mobilized peripheral blood-derived NOD/SCID repopulating cells by foamy virus vectors. Hum. Gene Ther. 15:87-92.
25. Josephson, N. C., G. Vassilopoulos, G. D. Trobridge, G. V. Priestley, B. L. Wood, T. Papayannopoulou, and D. W. Russell. 2002. Transduction of human NOD/SCID-repopulating cells with both lymphoid and myeloid potential by foamy virus vectors. Proc. Natl. Acad. Sci. U. S. A. 99:8295-8300.
26. Junghans, R. P., L. R. Boone, and A. M. Skalka. 1982. Products of reverse transcription in avian retrovirus analyzed by electron microscopy. J. Virol. 43:544-554.
27. Katz, R. A., C. A. Omer, J. H. Weis, S. A. Mitsialis, A. J. Faras, and R. V. Guntaka. 1982. Restriction endonuclease and nucleotide sequence analyses of molecularly cloned unintegrated avian tumor virus DNA: structure of large terminal repeats in circle junctions. J. Virol. 42:346-351.
28. Kim, S., K. Lee, M.-D. Kim, S. Kang, C. W. Joo, J.-M. Kim, S. H. Kim, S. S. Yu, and S. Kim. 2006. Factors affecting the performance of different long terminal repeats in the retroviral vector. Biochem. Biophys. Res. Commun. 343:1017-1022.
29. Leavitt, A., G. Robles, N. Alesandro, and H. Varmus. 1996. Human immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity yet fail to integrate viral DNA efficiently during infection. J. Virol. 70:721-728.
30. Leurs, C., M. Jansen, K. E. Pollok, M. Heinkelein, M. Schmidt, M. Wissler, D. Lindemann, C. von Kalle, A. Rethwilm, D. A. Williams, and H. Hanenberg. 2003. Comparison of three retroviral vector systems for transduction of nonobese diabetic/severe combined immunodeficiency mice repopulating human CD34 cord blood cells. Hum. Gene Ther. 14:509-519.
31. Li, L., J. M. Olvera, K. E. Yoder, R. S. Mitchell, S. L. Butler, M. Lieber, S. L. Martin, and F. D. Bushman. 2001. Role of the non-homologous DNA end joining pathway in the early steps of retroviral infection. EMBO J. 20:3272-3281.
32. Lin, Y., and A. S. Waldman. 2001. Capture of DNA sequences at double-strand breaks in mammalian chromosomes. Genetics 158:1665-1674.
33. 1/S phase-arrested cells, and integrase is critical for preintegration complex transport into the nucleus. J. Virol. 84:2832-2842.
34. Lombardo, A., P. Genovese, C. M. Beausejour, S. Colleoni, Y. L. Lee, K. A. Kim, D. Ando, F. D. Urnov, C. Galli, P. D. Gregory, M. C. Holmes, and L. Naldini. 2007. Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nat. Biotechnol. 25:1298-1306.
35. Meiering, C. D., K. E. Comstock, and M. L. Linial. 2000. Multiple integrations of human foamy virus in persistently infected human erythroleukemia cells. J. Virol. 74:1718-1726.
36. Miller, D. G., L. M. Petek, and D. W. Russell. 2003. Human gene targeting by adeno-associated virus vectors is enhanced by DNA double-strand breaks. Mol. Cell. Biol. 23:3550-3557.
37. Miller, M., B. Wang, and F. Bushman. 1995. Human immunodeficiency virus type 1 preintegration complexes containing discontinuous plus strands are competent to integrate in vitro. J. Virol. 69:3938-3944.
38. Moebes, A., J. Enssle, P. D. Bieniasz, M. Heinkelein, D. Lindemann, M. Bock, M. O. McClure, and A. Rethwilm. 1997. Human foamy virus reverse transcription that occurs late in the viral replication cycle. J. Virol. 71:7305-7311. (Pubitemid 27391668)
39. Naldini, L., U. Blomer, P. Gallay, D. Ory, R. Mulligan, F. H. Gage, I. M. Verma, and D. Trono. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267.
40. Neves, M., J. Peries, and A. Saib. 1998. Study of human foamy virus proviral integration in chronically infected murine cells. Res. Virol. 149:393-401.
41. Nightingale, S. J., R. P. Hollis, K. A. Pepper, D. Petersen, X. J. Yu, C. Yang, I. Bahner, and D. B. Kohn. 2006. Transient gene expression by nonintegrating lentiviral vectors. Mol. Ther. 13:1121-1132.
42. Philippe, S., C. Sarkis, M. Barkats, H. Mammeri, C. Ladroue, C. Petit, J. Mallet, and C. Serguera. 2006. Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo. Proc. Natl. Acad. Sci. U. S. A. 103:17684-17689.
43. Philpott, N. J., and A. J. Thrasher. 2007. Use of nonintegrating lentiviral vectors for gene therapy. Hum. Gene Ther. 18:483-489.
44. Rasheed, S., W. A. Nelson-Rees, E. M. Toth, P. Arnstein, and M. B. Gardner. 1974. Characterization of a newly derived human sarcoma cell line (HT-1080). Cancer 33:1027-1033.
45. Rethwilm, A. 2007. Foamy virus vectors: an awaited alternative to gammaretro- and lentiviral vectors. Curr. Gene Ther. 7:261-271.
46. Roy, J., W. Rudolph, T. Juretzek, K. Gartner, M. Bock, O. Herchenroder, D. Lindemann, M. Heinkelein, and A. Rethwilm. 2003. Feline foamy virus genome and replication strategy. J. Virol. 77:11324-11331.
47. Russell, D., and A. Miller. 1996. Foamy virus vectors. J. Virol. 70:217-222.
48. Saenz, D. T., N. Loewen, M. Peretz, T. Whitwam, R. Barraza, K. G. Howell, J. M. Holmes, M. Good, and E. M. Poeschla. 2004. Unintegrated lentivirus DNA persistence and accessibility to expression in nondividing cells: analysis with class I integrase mutants. J. Virol. 78:2906-2920.
49. Saib, A., F. Puvion-Dutilleul, M. Schmid, J. Peries, and H. de The. 1997. Nuclear targeting of incoming human foamy virus Gag proteins involves a centriolar step. J. Virol. 71:1155-1161.
50. Salomon, B., S. Maury, L. Loubiere, M. Caruso, R. Onclercq, and D. Klatzmann. 1995. A truncated herpes simplex virus thymidine kinase phosphorylates thymidine and nucleoside analogs and does not cause sterility in transgenic mice. Mol. Cell. Biol. 15:5322-5328.
51. Schwartz, F., N. Maeda, O. Smithies, R. Hickey, W. Edelmann, A. Skoultchi, and R. Kucherlapati. 1991. A dominant positive and negative selectable gene for use in mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 88:10416-10420.
52. Shank, P. R., S. H. Hughes, H. J. Kung, J. E. Majors, N. Quintrell, R. V. Guntaka, J. M. Bishop, and H. E. Varmus. 1978. Mapping unintegrated avian sarcoma virus DNA: termini of linear DNA bear 300 nucleotides present once or twice in two species of circular DNA. Cell 15:1383-1395.
53. Swanstrom, R., W. J. DeLorbe, J. M. Bishop, and H. E. Varmus. 1981. Nucleotide sequence of cloned unintegrated avian sarcoma virus DNA: viral DNA contains direct and inverted repeats similar to those in transposable elements. Proc. Natl. Acad. Sci. U. S. A. 78:124-128.
54. Trobridge, G., N. Josephson, G. Vassilopoulos, J. Mac, and D. W. Russell. 2002. Improved foamy virus vectors with minimal viral sequences. Mol. Ther. 6:321-328.
55. Trobridge, G., and D. W. Russell. 2004. Cell cycle requirements for transduction by foamy virus vectors compared to those of oncovirus and lentivirus vectors. J. Virol. 78:2327-2335.
56. Varga, T., and P. D. Aplan. 2005. Chromosomal aberrations induced by double strand DNA breaks. DNA Repair 4:1038-1046.
57. Vargas, J., Jr., G. L. Gusella, V. Najfeld, M. E. Klotman, and A. Cara. 2004. Novel integrase-defective lentiviral episomal vectors for gene transfer. Hum. Gene Ther. 15:361-372.
58. Vassilopoulos, G., G. Trobridge, N. C. Josephson, and D. W. Russell. 2001. Gene transfer into murine hematopoietic stem cells with helper-free foamy virus vectors. Blood 98:604-609.
59. Wanisch, K., and R. J. Yanez-Munoz. 2009. Integration-deficient lentiviral vectors: a slow coming of age. Mol. Ther. 17:1316-1332.
60. Yanez-Munoz, R. J., K. S. Balaggan, A. MacNeil, S. J. Howe, M. Schmidt, A. J. Smith, P. Buch, R. E. MacLaren, P. N. Anderson, S. E. Barker, Y. Duran, C. Bartholomae, C. von Kalle, J. R. Heckenlively, C. Kinnon, R. R. Ali, and A. J. Thrasher. 2006. Effective gene therapy with nonintegrating lentiviral vectors. Nat. Med. 12:348-353.
61. Yu, S. F., D. N. Baldwin, S. R. Gwynn, S. Yendapalli, and M. L. Linial. 1996. Human foamy virus replication: a pathway distinct from that of retroviruses and hepadnaviruses. Science 271:1579-1582.
62. Yu, S. F., M. D. Sullivan, and M. L. Linial. 1999. Evidence that the human foamy virus genome is DNA. J. Virol. 73:1565-1572.
63. Yu, S. S., K. Dan, H. Chono, E. Chatani, J. Mineno, and I. Kato. 2008. Transient gene expression mediated by integrase-defective retroviral vectors. Biochem. Biophys. Res. Commun. 368:942-947.